Bristol-Myers Squibb (BMY) to Highlight Clinical and Translational Research at SITC
Tweet Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) today announced that 23 abstracts spanning its expansive oncology research program will be presented at ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
